The FDA has granted PREZISTA (darunavir) tablets, a protease inhibitor, approval for an expanded indication for once-daily dosing as part of HIV combination therapy in treatment-naive adults (those who have never taken HIV medication before). The FDA also granted traditional (full) approval to PREZISTA as twice-daily for use in treatment-experienced adult patients.
The details can be read here.
1 comment:
This is a good step which FDA had taken for an approval of HIV combination therapy in the treatment. i know one more resource about the same which provides medicines for treatment like generic flomax
Post a Comment